2020 Year in Review: COVID-19 Innovation
Scientists, health care professionals and government leaders across the Middle East and North Africa have collaborated this year to find innovative solutions to the ongoing COVID-19 pandemic. While it’s been an unprecedented year, it has also spurred immense biopharmaceutical research and development as industry innovators worked to leverage decades of research and scientific knowledge to develop new treatments and vaccines.
ICYMI: G20 and World Health Assembly leaders support efforts to defeat COVID-19
While the COVID-19 pandemic continues to have an unprecedented impact on the health of communities and global economies, government leaders at the G20 and World Health Assembly discussed various approaches to controlling the spread of COVID-19 through science-based solutions.
Interview Spotlight: Samir Khalil, Executive Director of PhRMA Middle East and Africa
In a recent interview with Asharq Alawsat, Samir Khalil, Executive Director of the Pharmaceutical Research and Manufacturers of America (PhRMA) Middle East and Africa, discussed the ongoing need for strong intellectual property (IP) protections, increased investment in biopharmaceutical research and development and global collaboration to foster a robust innovation ecosystem in Saudi Arabia.
IP20+ Virtual Forum Underscores Importance of Intellectual Property in Ending Pandemic
Saudi Arabia recently hosted the IP20+ Global Intellectual Property Challenges forum, bringing together the World Intellectual Property Organization (WIPO) and leaders of intellectual property (IP) offices across G20 countries to establish priorities in response to the COVID-19 pandemic and future emergencies.